Stay informed with the latest updates for the inheritable blood disorders community. Industry Freeline Provides Updates on Hemophilia Gene Therapy ProgramsJul 29, 2019 Joint Statement on Recall of Bayer Kogenate® FS LotsJul 26, 2019 Industry Investigators Report Progress on New Subcutaneous TherapyJul 25, 2019 Industry Casebia Presents Dual Approach to Gene TherapyJul 23, 2019 Industry Sanofi Presents Final Trial Data for rFVIII CandidateJul 22, 2019 Industry BioMarin to Submit Marketing Applications to FDA and EMAJul 22, 2019 Medical Advisory Medical Advisory #425: Bayer Announces a Voluntary Recall of Two…Jul 19, 2019 Industry uniQure Announces New Gene Therapy Trial DataJul 18, 2019 Industry Genentech Announces New Data from Hemlibra® Clinical Trial ProgramJul 11, 2019 Industry Octapharma Presents Final Data on Personalized Therapy with Nuwiq®Jul 11, 2019 NHF Joins Organizations Urging Court to Protect ACAJul 9, 2019 A Priceless ExperienceJul 9, 2019 Industry Sangamo and Pfizer Announce Interim Gene Therapy Findings Jul 9, 2019 Medical Comparing Adherence and Physical Activity in Hemophilia A PatientsJul 2, 2019 NHF-McMasters Guidelines on ECRIJun 19, 2019 Pagination First page Previous page … Page 36 Page 37 Page 38 Page 39 Current page 40 Page 41 Page 42 Page 43 Page 44 … Next page Last page
